66
PS/APP
These double transgenic mice were generated by crossing mice overexpressing human APP with the Swedish mutation driven by APP, the hamster prion protein gene promoter (the Tg2576 model) PSEN1 with mice overexpressing human PSEN1 with the M146L mutation driven by the PDGF-β promoter (PSEN1(M146L), line 5.1). The two transgenes segregate independently.
67
PS cDKO
To generate forebrain-specific conditional double knockout mice PSEN1 lacking both PS1 and PS2 (PS cDKO) mice, floxed PS1 (fPS1), α , CaMKII-Cre transgenic mice and PS2-/- mice were crossed PSEN2 together to obtain fPS1/fPS1;αCaMKII-Cre;PS2-/- mice. A targeting vector containing a neomycin resistance gene was inserted downstream of exon 7 of PSEN1; loxP sites were PSEN1 inserted on both sides of exon 7 and downstream of the neomycin resistance gene.
68
PSEN1-flox
69
PSEN1 Knock- PSEN1 A targeting construct containing a neomycin cassette was used to disrupt exons 2 and 3 of the endogenous mouse PS1 gene. out Point mutations were introduced into exon 5 of the endogenous mouse PSEN1
gene altering the codons corresponding to amino PSEN1(M146V) PSEN1 acids 145 and 146 from isoleucine and methionine to valine and valine, respectively. The targeting vector contained a lox-P Knock-In flanked neomycin resistance cassette and herpes simplex virus thymidine kinase genes.
70
71 72
PSEN1(P117L) PSEN1 Transgene of human PSEN1 with the P117L mutation driven by the neuron specific enolase (NSE) promoter. (line 13) PSEN1(WT) PSEN1-YAC (line G9) PSEN1 Human wild-type PSEN1 driven by neuron-specific enolase (NSE).
73
A 1000 kb YAC transgene (788H12) containing the entire human PSEN1 PSEN1 gene with the H163R mutation. Transgene also has ~550 kb of upstream and 350 kb of downstream flanking sequences. A targeting vector containing a hygromycin resistance gene
74
PSEN2 Knock- PSEN2 driven by the phosphoglycerate kinase promoter was used to disrupt exon 5 of PSEN2 by introducing a frame shift between out exons 4 and 6.
75
rTg(tauP301L MAPT )4510
Transgene has human four-repeat MAPT lacking the amino terminal sequence (4R0N) with the P301L mutation. Expression is driven by a tetracycline operator (tetO) upstream of a cytomegalovirus minimal promoter and contains exons 2-3 of the mouse prion protein gene (Prnp) untranslated sequence.

Regimen Summary of Peptide Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD...
第二节 阿尔茨海默病(Alzheimer's disease,AD)阿尔茨海默病(Alzheimer's disease,AD) ,是发生于老年和老年前期、以 进行性认知功能障碍和行为损害为特征的中枢...
Medicines for Alzheimer’ Disease (AD) Treatment ---Summarized peptide regimen for in vivo AD study Animal Study Model 3xTg-AD Transgenic Mice Medicine ?...
阿尔茨海默病(Alzheimer’SDisease,AD)与动力相关蛋白1(dynamin—relatedprotein1,Drp1)_基础医学_医药卫生_专业资料。第3 0卷第 2期 201 3年 4月 生物学...
让我们向江教练致敬,并祝老年痴呆症患者早日康复! 治疗老年痴呆症的小偏方所谓的老年痴呆症,又称阿尔茨海默病(alzheimer's disease,ad)是发生在老年期及老年前期...
b.老年痴呆病 老年性痴呆病,分为阿尔茨海默病(Alzheimer’sdisease,AD)和血管性痴呆(VD) ,是一 种发病于老年期前后的原发性大脑退行性疾病。 近年来老年性痴呆...
老年痴呆症的护理 老年痴呆症又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期及老年前期的一种 原发性退行性脑病, 指的是一种持续性高级神经功能...
In order to study AD pathology and develop AD ...Using Tg6799 as a mouse model for AD research ...(Alzheimer’s disease,AD)又称老年痴呆症,是一...
Alzheimer's disease 老年痴呆症Alzheimer's disease 老年痴呆症隐藏>> review article Pathways towards and away from Alzheimer’s disease Mark P. Mattson ...
老年痴呆症,又称阿尔茨海默病 (Alzheimer's disease,AD) 是发生在老年期 及老年前期的一种原发性退行性脑病,指 的是一种持续性高级神经功能活动障碍, 即在没...
热门文档